Technical Analysis for ALEC - Alector, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.72 | 2.34% | 0.09 |
ALEC closed down 5.58 percent on Wednesday, November 20, 2024, on 86 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 2.34% | |
| 180 Bearish Setup | Bearish Swing Setup | 2.34% | |
| Stochastic Buy Signal | Bullish | 2.34% | |
| NR7 | Range Contraction | 2.34% | |
| Lower Bollinger Band Walk | Weakness | 2.34% | |
| Inside Day | Range Contraction | 2.34% | |
| Wide Bands | Range Expansion | 2.34% | |
| Below Lower BB | Weakness | 2.34% | |
| Lower Bollinger Band Touch | Weakness | 2.34% | |
| Oversold Stochastic | Weakness | 2.34% |
| Alert | Time |
|---|---|
| Up 2% | about 1 hour ago |
| 60 Minute Opening Range Breakout | about 1 hour ago |
| Lower Bollinger Band Support | about 1 hour ago |
| 1.5x Volume Pace | about 2 hours ago |
| Down 3% | about 3 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/05/2024
Alector is pioneering immuno-neurology, a novel therapeutic approach to counteract the multiple pathologies that cause degenerative brain disorders by restoring healthy immune function to the brain. Supporting its scientific approach, the Company’s Discovery Platform enables them to advance a broad portfolio of product candidates, validated by human genetics, which they believe will improve the probability of technical success of these product candidates and shorten the development timelines to bring these therapies to patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Immune System Genetics Urology Neurology Brain Disorders
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Immunology Immune System Genetics Urology Neurology Brain Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 8.9 |
| 52 Week Low | 3.57 |
| Average Volume | 626,170 |
| 200-Day Moving Average | 5.38 |
| 50-Day Moving Average | 4.99 |
| 20-Day Moving Average | 4.92 |
| 10-Day Moving Average | 4.83 |
| Average True Range | 0.41 |
| RSI (14) | 32.89 |
| ADX | 22.33 |
| +DI | 17.64 |
| -DI | 36.02 |
| Chandelier Exit (Long, 3 ATRs) | 4.90 |
| Chandelier Exit (Short, 3 ATRs) | 4.81 |
| Upper Bollinger Bands | 6.21 |
| Lower Bollinger Band | 3.63 |
| Percent B (%b) | 0.0 |
| BandWidth | 52.27 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.05 |
| MACD Histogram | -0.2013 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 3.99 | ||||
| Resistance 3 (R3) | 4.02 | 3.93 | 3.93 | ||
| Resistance 2 (R2) | 3.93 | 3.84 | 3.92 | 3.91 | |
| Resistance 1 (R1) | 3.78 | 3.78 | 3.74 | 3.75 | 3.89 |
| Pivot Point | 3.69 | 3.69 | 3.67 | 3.68 | 3.69 |
| Support 1 (S1) | 3.54 | 3.60 | 3.50 | 3.52 | 3.38 |
| Support 2 (S2) | 3.45 | 3.55 | 3.44 | 3.36 | |
| Support 3 (S3) | 3.31 | 3.45 | 3.34 | ||
| Support 4 (S4) | 3.28 |
